Hikmet Al‐Hiti

Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial

Nazzareno Galiè, LJ Rubin, Pavel Jansa et al. · The Lancet · 2008 · 913 citations

Hypertension, Pulmonary Arterial Hypertension, Cardiovascular Disease +9

Macitentan in pulmonary hypertension due to left ventricular dysfunction

Jean‐Luc Vachiéry, Marion Delcroix, Hikmet Al‐Hiti et al. · European Respiratory Journal · 2018 · 193 citations · Full text

Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial

Marius M. Hoeper, Hikmet Al‐Hiti, Raymond L. Benza et al. · The Lancet Respiratory Medicine · 2021 · 151 citations

Hypertension, Pulmonary Arterial Hypertension, Phosphodiesterase-5 Inhibitors +11

Epidemiology and long-term survival of pulmonary arterial hypertension in the Czech Republic: a retrospective analysis of a nationwide registry

Pavel Jansa, Jiří Jarkovský, Hikmet Al‐Hiti et al. · BMC Pulmonary Medicine · 2014 · 74 citations · Full text

Transpulmonary B-Type Natriuretic Peptide Uptake and Cyclic Guanosine Monophosphate Release in Heart Failure and Pulmonary Hypertension

Vojtěch Melenovský, Hikmet Al‐Hiti, Ludmila Kazdová et al. · Journal of the American College of Cardiology · 2009 · 71 citations

Hypertension, Heart Failure, Pulmonary Arterial Hypertension +12